Abstract
Family C of the superfamily of G-protein coupled receptors is a growing family of heptahelical receptors, which includes, among others, metabotropic glutamate receptors (mGluRs) and GABA(B) receptors. A common feature of all the members of family C is a structural architecture much more complex than any other GPCRs. Computational studies, including homology modeling, pharmacophore definitions and molecular dynamics simulations have constantly flanked experimental approaches in the understanding of the receptor functioning. The present review will discuss the evolution of our perception in family C GPCRs structure and function as emerged from the critical comparison of in silico methods with molecular biology and crystallographic experiments.
Keywords: GPCRs, Metabotropic glutamate receptors, Venus flytrap, homology modeling, Extracellular domain
Current Pharmaceutical Design
Title: In Silico Approaches Towards the Understanding of the Structure- Function Relationships in Metabotropic Glutamate Receptors (mGluRs) and other Family C GPRCs
Volume: 12 Issue: 17
Author(s): Gabriele Costantino
Affiliation:
Keywords: GPCRs, Metabotropic glutamate receptors, Venus flytrap, homology modeling, Extracellular domain
Abstract: Family C of the superfamily of G-protein coupled receptors is a growing family of heptahelical receptors, which includes, among others, metabotropic glutamate receptors (mGluRs) and GABA(B) receptors. A common feature of all the members of family C is a structural architecture much more complex than any other GPCRs. Computational studies, including homology modeling, pharmacophore definitions and molecular dynamics simulations have constantly flanked experimental approaches in the understanding of the receptor functioning. The present review will discuss the evolution of our perception in family C GPCRs structure and function as emerged from the critical comparison of in silico methods with molecular biology and crystallographic experiments.
Export Options
About this article
Cite this article as:
Costantino Gabriele, In Silico Approaches Towards the Understanding of the Structure- Function Relationships in Metabotropic Glutamate Receptors (mGluRs) and other Family C GPRCs, Current Pharmaceutical Design 2006; 12 (17) . https://dx.doi.org/10.2174/138161206777585210
DOI https://dx.doi.org/10.2174/138161206777585210 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
High Dose Zolpidem Induced Fetal Neural Tube Defects
Current Drug Safety Nanoceuticals as an Emerging Field: Current Status and Future Prospective
Current Nutrition & Food Science Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics Endocrine Disruptors and Human Health
Mini-Reviews in Medicinal Chemistry Infrared-Spectroscopy: A Non-Invasive Tool for Medical Diagnostics and Drug Analysis
Current Medicinal Chemistry Recent Progress in Biological Activities of Indole and Indole Alkaloids
Mini-Reviews in Medicinal Chemistry Microglial Activation as a Compelling Target for Treating Acute Traumatic Brain Injury
Current Medicinal Chemistry Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides
Recent Patents on Drug Delivery & Formulation Viruses and Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Application of Microdialysis in Clinical Pharmacology
Current Clinical Pharmacology Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
Recent Patents on CNS Drug Discovery (Discontinued) Purinergic Signalling and Neurological Diseases: An Update
CNS & Neurological Disorders - Drug Targets Efficient High-throughput Techniques for the Analysis of Disease- Resistant Plant Varieties and Detection of Food Adulteration
Current Protein & Peptide Science Pharmacological Regulators of Intracellular Calcium Release Channels
Current Pharmaceutical Design Anticonvulsant Activity of New GABA Prodrugs
Medicinal Chemistry Synthesis of Poison-Frog Alkaloids and Their Pharmacological Effects at Neuronal Nicotinic Acetylcholine Receptors
Current Chemical Biology Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Screening the Receptorome Yields Validated Molecular Targets for Drug Discovery
Current Pharmaceutical Design Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
Current Medicinal Chemistry Homocysteine and Folate Therapy in Dialysis Patients
Letters in Drug Design & Discovery